Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma.

Tokura Y, Ishihara S, Tagawa S, Seo N, Ohshima K, Takigawa M.

J Am Acad Dermatol. 2001 Oct;45(4):569-78. Review.

PMID:
11568749
2.

Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease.

Ishihara S, Yabuta R, Tokura Y, Ohshima K, Tagawa S.

Int J Hematol. 2000 Aug;72(2):223-8. Review.

PMID:
11039673
3.
4.

Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.

Yachie A, Kanegane H, Kasahara Y.

Semin Hematol. 2003 Apr;40(2):124-32. Review.

PMID:
12704589
5.

Clinical categories of exaggerated skin reactions to mosquito bites and their pathophysiology.

Tatsuno K, Fujiyama T, Matsuoka H, Shimauchi T, Ito T, Tokura Y.

J Dermatol Sci. 2016 Jun;82(3):145-52. doi: 10.1016/j.jdermsci.2016.04.010. Epub 2016 Apr 30. Review.

PMID:
27177994
6.

[Diagnosis and treatment of chronic active EBV infection].

Kawa K.

Uirusu. 2002 Dec;52(2):257-60. Review. Japanese. No abstract available.

7.

Epstein-Barr virus-associated lymphomas.

Gandhi MK.

Expert Rev Anti Infect Ther. 2006 Feb;4(1):77-89. Review.

PMID:
16441211
8.

[Clinical characteristics of Epstein-Barr virus-associated natural killer cell lymphoma/leukemia].

Kawa K.

Nihon Rinsho. 1997 Feb;55(2):424-8. Review. Japanese.

PMID:
9046835
9.

Mucocutaneous manifestations of Epstein-Barr virus infection.

Mendoza N, Diamantis M, Arora A, Bartlett B, Gewirtzman A, Tremaine AM, Tyring S.

Am J Clin Dermatol. 2008;9(5):295-305. Review.

PMID:
18717604
11.

[Hypersensitivity to mosquito bites and hydroa vacciniforme].

Iwatsuki K, Yamamoto T, Tsuji K.

Nihon Rinsho. 2006 Mar;64 Suppl 3:657-61. Review. Japanese. No abstract available.

PMID:
16615554
12.

Epstein-Barr virus-associated lymphoproliferative disorders.

Rezk SA, Weiss LM.

Hum Pathol. 2007 Sep;38(9):1293-304. Review.

13.

[NK-cell lymphoma: pathogenesis and clinical features].

Suzumiya J.

Rinsho Ketsueki. 2008 Aug;49(8):545-52. Review. Japanese. No abstract available.

PMID:
18800600
14.
15.

Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.

Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK; CAEBV Study Group.

Pathol Int. 2008 Apr;58(4):209-17. doi: 10.1111/j.1440-1827.2008.02213.x. Review.

PMID:
18324913
16.

The pathology of NK-cell lymphomas and leukemias.

Nava VE, Jaffe ES.

Adv Anat Pathol. 2005 Jan;12(1):27-34. Review.

PMID:
15614162
18.

Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias.

Cheung MM, Chan JK, Wong KF.

Semin Hematol. 2003 Jul;40(3):221-32. Review.

PMID:
12876671
19.
20.

Supplemental Content

Support Center